Furthermore, the level of TAZ expression in hepatocytes was elevated in a murine model of NASH, and the silencing of TAZ in the NASH model prevented or reversed inflammation, hepatocyte death, and hepatic fibrosis although there was no significant changes in the degree of steatosis. The gene discussed is WWTR1; the disease is metabolic dysfunction-associated steatohepatitis.